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BPI-fold (BPIF) containing/plunc protein 
expression in human fetal major and 
minor salivary glands 
Abstract: The aim of this study was to determine expression, not 
previously described, of PLUNC (palate, lung, and nasal epithelium 
clone) (BPI-fold containing) proteins in major and minor salivary glands 
from very early fetal tissue to the end of the second trimester and thus 
gain further insight into the function of these proteins. Early fetal heads, 
and major and minor salivary glands were collected retrospectively 
and glands were classified according to morphodifferentiation stage. 
Expression of BPI-fold containing proteins was localized through 
immunohistochemistry. BPIFA2, the major BPI-fold containing protein in 
adult salivary glands, was detected only in the laryngeal pharynx; the lack 
of staining in salivary glands suggested salivary expression is either very 
late in development or is only in adult tissues. Early expression of BPIFA1 
was seen in the trachea and nasal cavity with salivary gland expression 
only seen in late morphodifferentiation stages. BPIFB1 was seen in early 
neural tissue and at later stages in submandibular and sublingual glands. 
BPIFA1 is significantly expressed in early fetal oral tissue but BPIFB1 has 
extremely limited expression and the major salivary BPIF protein (BPIFA2) 
is not produced in fetal development. Further studies, with more sensitive 
techniques, will confirm the expression pattern and enable a better 
understanding of embryonic BPIF protein function.
Keywords: Immunity, Innate; Immunohistochemistry; Humans; 
Salivary Glands.
Introduction
The BPI-fold (BPIF) containing/Plunc (palate, lung, and nasal epithelium 
clone) family of putative innate defence genes is located in a single locus on 
human chromosome 20q11.2, and members of the family are predominantly 
expressed in regions of the oral cavity, nasopharynx and upper respiratory 
tract.1 Protein expression of the prototypic family member, BPIFA1/Plunc, 
(palate, lung and nasal epithelium clone) was first described in the nasal 
epithelium of the mouse embryo and the trachea/bronchi of adult mice.2 
An extended family of proteins was subsequently identified, and these 
are now known to make up the largest branch of a lipid transfer protein 
family that includes phospholipid transfer protein (PLTP), cholesterol ester 
transfer protein (CETP), bactericidal permeability increasing protein (BPI) 
and LPS-binding protein (LBP).3,4,5 The considerable structural similarity 
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across the PLUNC/BPI family suggested that PLUNC 
proteins might function by binding lipid molecules 
and this led to the hypothesis that PLUNCs may 
share host defence functions with BPI and LBP.6,7,8 
BPIF proteins exist as two subgroups; BPIFA 
proteins (formally SPLUNCs) and BPIFB proteins 
(formally LPLUNCs). BPIFA proteins have structural 
homology to the N-terminal domain of BPI whereas 
BPIFB proteins have structural homology to both 
domains of BPI.4,7 
BPIF proteins appear to exhibit distinct tissue 
and cell specific expression patterns with various 
family members being localised to a number of 
different glandular structures within the upper 
respiratory tract, nasopharyngeal regions and oral 
cavity.1 The proteins are secreted from these tissues 
and are found in high levels in saliva and nasal 
and respiratory lining fluids. Expression studies on 
the human proteins have largely focused on a few 
members of the family, including BPIFA1, BPIFA2, 
and BPIFB1, and have largely been carried out on 
adult tissues.9,10,11,12 Expression and localization of the 
proteins in developing tissues has been given little 
attention since the first description of BPIFA1 (PLUNC) 
by Weston et al.2 To date only one study, by Zhou et al.,13 
has investigated BPIF protein expression in human 
fetal tissue. They carried out an immunohistochemical 
study on 37 different tissues from on 28–30 week 
human fetuses and found positive BPIFA1 expression 
in all of the major salivary glands. They described 
positive expression in both serous and mucus cells, 
which is in contrast to previous studies carried out 
with adult tissues where expression appears to be 
limited to mucus cells.10,11 
The aim of this study was to assess the 
immunohistochemical expression pattern of three 
BPIF proteins in head and neck tissues from very 
early human fetuses and in the major and minor 
salivary glands, tongue and palate of later-stage 
human fetuses.
Methodology 
Sample Characteristics
The Human Developmental Biology Resource 
(Newcastle, UK) provided fetal head sections (eight, 
nine, and 12 weeks). Archived formalin-fixed, 
paraffin-embedded tissue blocks of salivary 
glands, palate, and tongue of 26 human fetuses 
(12 to 25 intrauterine weeks) were obtained from the 
Department of General Pathology, School of Dentistry, 
University of São Paulo, Brazil. Twenty-five major 
salivary glands were collected, comprising seven 
parotid, 13 submandibular and five sublingual glands 
and 33 minor salivary glands from the lip (n = 18), 
tongue (n = 6), and palate (n = 9). Ethical approval for 
this study was granted by the Newcastle and North 
Tyneside Local Research Ethics Committee and by 
the Research Ethics Committee of the Faculty of 
Dentistry, Piracicaba, State University of Campinas 
(FOP-UNICAMP Protocol Number 114/2009), Brazil.
Immunohistochemical analysis
The study was carried out using immunohistochemical 
techniques described previously in detail.10,14 BPIFA2 
antibodies were custom made, affinity-purified, 
anti-peptide antibodies from Eurogentec with full 
characterization, as described in Bingle et al.12 Briefly, 
all tissues were formalin-fixed and paraffin embedded 
and 4 μM sections were treated with 3% hydrogen 
peroxide in methanol to quench endogenous peroxidase. 
Sections to be incubated with BPIFA2A were subjected 
to antigen retrieval; they were immersed in 0.01 M 
sodium citrate and microwaved for 8 min.12 Sections 
were incubated with 100% normal goat serum at room 
temperature for 30 min and then at 4°C overnight with 
affinity purified polyclonal primary antibodies diluted 
in 100% goat serum (Sigma-Aldrich, Gillingham, 
Dorset, UK; BPIFA2A [1:250], BPIFA2B [1:500] and 
BPIFB1 [1:600]). We also used a polyclonal BPIFA1 
antibody (1:300 dilution), as described by Campos et 
al.15 Rabbit IgG (DAKO, Ely, Cambridgeshire, UK) was 
used as a negative control. A Vectastain Elite ABC kit 
(Vector Laboratories, Peterborough, Northants, UK) 
containing an appropriate biotin-labeled secondary 
antibody was used, according to the manufacturer’s 
instructions. Peroxidase enzymatic development 
was performed using a Vector NovaRed substrate kit 
(Vector Laboratories, Peterborough, Northants, UK) 
resulting in red staining in positive cells. Sections were 
counterstained with hematoxylin, dehydrated to xylene, 
and mounted in DPX. 
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The respiratory epithelium of the palate region 
and the tongue surface epithelium were also assessed 
for expression of BPIFA1, BPIFA2 and BPIFB1.
Morphodifferentiation stages
To evaluate immunohistochemical expression 
patterns, the major and minor salivary glands were 
classified according to the five morphodifferentiation 
stages (prebud, initial bud, pseudoglandular, canalicular, 
and terminal bud stages) described by Tucker.16 
Evaluation of immunohistochemical 
staining
Immunohistochemical staining with all antibodies 
in all tissues was classified as either positive or negative.
Results 
Whole fetal heads from eight to 12 week fetuses 
were analyzed alongside major and minor salivary 
glands from 26 fetuses, which were assessed according 
to the location of the gland and the predominant 
morphodifferentiation stage (Table 1). 
In the early stages of development (eight and nine 
week fetuses), BPIFA1 specific staining was limited to 
the epithelial cells lining the nasal cavity, nasal capsule 
and laryngeal pharynx (Figure 1), and also the surface 
cells of the tongue and rudimentary submandibular 
gland cells (Figure 2). Expression of BPIFA2 and BPIFB1 
was extremely limited with BPIFA2 only being detected 
in the laryngeal pharynx (Figure 3) and BPIFB1 being 
seen in small areas of the developing brain.
Tissues collected from later stages of development 
(intrauterine age 12 to 25 weeks) also showed limited 
expression of these proteins as only BPIFA1 and BPIFB1 
were detected; no BPIFA2 positive staining was ever 
seen in later stage tissues. BPIFA1 was detected in 
only 13 of the 26 fetuses studied but this did include 
all major and minor glands examined apart from 
the parotid gland. BPIFB1 exhibited a more limited 
expression profile as the protein was only detected 
in two of the 26 fetuses, one submandibular gland, 
and one sublingual gland (Table 2).
Of the total 58 salivary glands analyzed, 17 (29%) were 
positive for BPIFA1. Sixteen of the 58 glands were from 
the pseudoglandular stage but none of these expressed 
BPIFA1, 22 were at the canalicular stage, four (18%) of 
which expressed BPIFA1, and 20 were from the terminal 
bud stage with 13 (65%) expressing BPIFA1. Twenty-five 
major salivary glands were assessed. Eight were positive 
for BPIFA1, including four submandibular glands at the 
canalicular stage. Four of the five sublingual glands 
evaluated (80%) were positive for BPIFA1 and these 
predominantly had a terminal bud morphodifferentiation 
pattern. No parotid glands expressed BPIFA1 but this is 
in keeping with the expression pattern seen post-natally. 
Thirty-three minor salivary glands were examined and 
of these nine (27%) were positive for BPIFA1, all from 
the terminal bud morphodifferentiation stage. Four 
of the 18 lip glands (22%), two of the six tongue glands 
(33%) and three of the nine palate glands (33%) assessed 
were positive for BPIFA1. In glands in the canalicular 
stage, BPIFA1 was found in mucin plugs and within 
the primitive striated ducts (Figure 4), whereas in the 
glands in the terminal bud stage it was expressed in 
mucous cells of the primitive mucous tubules and in 
the cytoplasm of epithelial and myoepithelial cells of 
primitive acini (Figure 5). 
Table 1. Representation of the assessed samples according to the type of salivary gland and the predominant morphodifferentiation 
stage. N (%).
Location Pseudoglandular Canalicular Terminal bud Total
Parotid  2 (29%)  5 (71%) 0  7 (100%)
Submandibular 0 12 (92%) 1 (8%) 13 (100%)
Sublingual  1 (20%) 0 4 (80%)  5 (100%)
Palate  4 (44%)  1 (11%) 4 (44%)  9 (100%)
Lip  5 (28%)  4 (22%) 9 (50%) 18 (100%)
Tongue  4 (67%) 0 2 (33%)  6 (100%)
Total 16 22 20 58
N = number; (%) = percentage.
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BPIFB1 expression was much less frequently 
observed with only two of the 26 fetuses showing 
any positivity and then only in one submandibular 
and one sublingual gland. The distinct areas which 
appeared to be expressing BPIFB1, were the luminal 
poles of ductal cells (Figure 6).
During our evaluat ion of the major and 
minor salivary glands it was noted that some 
adjacent tissue types also stained positively for 
BPIFA1. For example, three of the six tongue 
sections demonstrated expression of BPIFA1 
in the squamous epithelium (Figure 7) and six 
of the nine minor glands from the palate had 
respiratory epithelium associated; ciliated cells 
from this region were strongly positive for BPIFA1 
(Figure 7). BPIFA2 and BPIFB1 were not expressed 
in the respiratory epithelium.
A B
C D
Figure 2. BPIFA1 expression in tongue and glands of 9 week 
fetal head. A: Low power image of rudimentary salivary glands 
and tongue epithelium; B: Higher power illustrating BPIFA1 
expression in early tongue epithelium; C and D: Higher power 
images depicting BPIFA1 in rudimentary submandibular gland. 
Magnification shown on image.
Figure 1. BPIFA1 expression in 8-week fetal head. A: Overview of structures in head section; B: Low power image depicting nasal 
cavity; C and D: Higher power images depicting positive BPIFA1 staining in nasal cavity. Magnification shown on image. 
B
C D
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Discussion
The function of the BPIF protein family has 
not yet been fully elucidated, although there is 
increasing evidence that it may play a role in innate 
immunity.7,17,18,19,20 The expression of a number of family 
members in adult human tissues is well documented 
but to date there is only one study describing expression 
in human fetal salivary gland tissue and that was 
limited to relatively late stage of development (28–30 
weeks).13 In the present study we have used whole 
head sections from 8–12 week fetuses and major and 
minor salivary glands from 12 to 25 weeks. 
None of the major or minor salivary glands 
evaluated in this study were positive for BPIFA2, the 
major BPIF protein secreted into adult saliva from 
all major and minor glands. Our previous studies 
have suggested that BPIFA2 is not only secreted from 
the serous cells20 but is also produced within the 
intralobular and interlobular ducts of the salivary 
glands and serous demilunes of the minor salivary 
glands.12 This is the first study to attempt to determine 
Table 2. Representation of all samples of major and minor 
salivary glands according to the expression of BPIFA1, 
BPIFA2A, BPIFA2B and BPIFB1. N.
Location BPIFA1 BPIFA2 BPIFB1
Parotid 0 0 0
Submandibular 4 0 1
Sublingual 4 0 1
Palate 3 0 0
Lip 4 0 0
Tongue 2 0 0
Total 17 0 2
N = positive samples.
Figure 3. BPIFA2 expression in laryngeal pharynx of 8 week fetal head. A: Overview of structures in head section; B: Low 
power image of laryngeal pharynx; C and D: Higher power images showing positive expression of BPIFA2 in laryngeal pharynx. 
Magnification shown on image.
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the expression of this protein in fetal tissue and our 
results suggest that production and secretion of BPIFA2 
is closely associated with the enzymatic activity of 
secretory granules of serous cells, which only occurs 
in the first week of life. In addition, rodent parotid 
secretory protein (PSP, homologous with human 
BPIFA2) is also only expressed post-natally.21,22,23 
We also previously described the expression 
of BPIFB1 in the duct cells of adult major salivary 
glands,14 but to date there are no studies that show 
expression in the salivary glands of human fetuses. 
In our study, BPIFB1 was only detected in neural 
tissue of the very early fetuses and in the luminal 
pole of duct cells in two of the major salivary glands 
examined; these were in the canalicular and terminal 
bud morphodifferentiation stages. As this protein 
was found in such a small number of the tissues 
examined, we suggest that further investigation 
using more sensitive laboratory techniques, such as 
in situ hybridization, is needed.
BPIFA1 protein was detected in the nasal cavity, 
nasal capsule, and laryngeal pharynx of the very 
early fetuses and in both major and minor salivary 
glands of 13 of the 26 later-stage human fetuses 
studied. Zhou et al.13 detected expression of BPIFA1 in 
Figure 4. BPIFA1 localization in canalicular and terminal 
bud stage salivary glands. A: Hematoxylin & Eosin (H&E), 
Submandibular gland, Canalicular stage, 21 weeks (original 
magnification 400X); B: Periodic Acid Schiff (PAS), mucin 
plug PAS positive (original magnification 400X); C: BPIFA1 
expression in mucin plug of striated duct (original magnification 
400X); D: BPIFA1 in mucin plug of striated duct (original 
magnification 1000X). 
A B
C D
Figure 5. BPIFA1 is also produced by fetal minor salivary 
glands. A: H&E, Minor salivary gland of lip, Terminal bud stage, 
22 weeks; B: BPIFA1 in mucous cells of the primitive mucous 
tubules; C: High power view of B; D: BPIFA1 in myoepithelial 
and ductal cells of primitive acini.
A B
C D
Figure 6. BPIFB1 is only expressed in a minority of fetal 
submandibular and sublingual glands. A: Submandibular 
gland, Canalicular stage, 21 weeks, BPIFB1 expression in 
luminal pole of ductal cells (original magnification 400X); B: 
High power view of A (original magnification 1000X). 
A B
Figure 7. Respiratory tissue associated with the tongue 
indicated epithelial cells early in development produce BPIFA1. 
A: Respiratory epithelium, 16 weeks, BPIFA1 expression 
in ciliated cells of the respiratory epithelium (original 
magnification 1000X); B: Tongue epithelium, 17 weeks, BPIFA1 
expression in the squamous epithelium of the tongue surface 
(original magnification 1000X). 
A B
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both mucous and serous cells of fetal submandibular 
glands but in our study submandibular expression of 
BPIFA1 occurred mainly in the mucin plugs of striated 
ducts. In adult glands the protein is only expressed 
in mucous cells of both major and minor glands.12 
Zhou et al.13 also found strong expression of BPIFA1 
in the parotid glands of their fetuses, however, none 
of the seven parotids evaluated in our study were 
positive for BPIFA1 or any other marker used, and 
BPIFA1 has never been detected in adult parotid 
glands. BPIFA2 is highly expressed in adult parotid 
glands and so it was somewhat surprising to note 
that the protein is not expressed in fetal glands. 
However, despite being the first salivary gland to 
form, development is slow with the first production 
of salivary proteins occurring between the 25th 
and 32nd weeks of intra-uterine life, and the first 
secretory granules forming after birth.21,22,23,24 This is 
all considerably later in development than the tissues 
we were able to obtain for evaluation. 
The expression of BPIFA1 in fetal sublingual 
glands and minor salivary glands has not previously 
been assessed. Bingle et al.12 detected the cytoplasmic 
expression of BPIFA1 protein in mucous acini and 
mucin plugs in the ducts of the sublingual glands and 
minor salivary glands of adults. In the present study, 
BPIFA1 localized mainly in the cytoplasm of mucous 
cells in the primitive tubules of sublingual glands, 
although in one case the cytoplasm of myoepithelial 
and ductal cells of primitive acini was also positive. 
BPIFA1 similarly localized in the cytoplasm of 
mucous cells in tubules from minor salivary glands 
of the lip, the palate, and the tongue and one gland 
associated with the tongue demonstrated BPIFA1 
protein production in the cytoplasm of ductal cells 
of primitive acini. This is therefore the first study 
to describe intrauterine expression of BPIFA1 in 
sublingual glands and minor salivary glands of the 
lip, palate and tongue region. Further studies are 
needed however, to elucidate the role of this protein 
in the embryonic period. 
The expression of the BPIFA1 protein in the 
epithelium of the upper airways of human adults is 
well described,10 however the function has also not 
yet been fully elucidated. Thus, various studies have 
investigated the relationship of these proteins in the 
host defense system against aggressive agents.25,26,27,28,29 
Ciliated cells found in respiratory epithelium adjacent 
to palatal minor salivary glands demonstrated 
positive expression of BPIFA1. We also found early 
expression (from eight weeks) in epithelial cells 
lining the nasal cavity, nasal capsule, and laryngeal 
pharynx and in surface cells of the tongue. LeClair et 
al.30 investigated the expression of BPIFA1 in murine 
embryonic epithelium of the nasopharynx and Zhou 
et al.13 observed expression in the squamous and 
columnar epithelium of the nose, palate, pharynx 
and tracheal region of late-stage human fetuses, but 
neither study described expression of BPIFA1 in the 
nasal septa. Further studies are needed to evaluate the 
expression of BPIFA1 in fetal respiratory epithelium 
as this has not previously been described and will 
further validate our initial findings. Such a study 
would also help to elucidate the role of BPIFA1 during 
this stage of human development. 
Whole head sections from the early stages of 
fetal development and lingual minor salivary 
glands indicated that BPIFA1 is also secreted from 
the squamous epithelium of the tongue surface. 
Interestingly we have found similar expression in 
adult tissue and LeClair et al. (2004) showed that a 
member of the BPIF family exclusive to mice, BPIFA5, 
was only expressed in the intrapapillar epithelium of 
the dorsal surface of the tongue.10,31 We believe this is 
the first time such expression has been demonstrated 
in human fetal tissue. 
The onset of BPIFA1 protein expression in 
human fetal salivary glands seems to be related to 
the morphodifferentiation stage of the gland as the 
BPIFA1-positive samples were predominantly associated 
with the more advanced morphodifferentiation stages 
(canalicular and terminal bud). According to Tucker16, 
the salivary glands, despite being well differentiated in 
these stages, will only reach full maturity in the postnatal 
period. Our results suggest that in the submandibular 
glands, BPIFA1 is produced during the canalicular 
stage of morphodifferentiation. However, not all 
submandibular glands demonstrated positive staining 
and it is difficult to explain why a significant number 
of submandibular glands at this stage (n = 8) and the 
sample collected from the terminal bud stage, did not 
appear to be producing the protein. The sublingual 
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glands and minor salivary glands of the lip, palate and 
tongue region seem to initiate the production of BPIFA1 
during the terminal bud stage, however, again this was 
not the case in all samples. The material used in this 
study, for the later stages of development, came from 
an archive that consisted of paraffin-embedded tissue 
blocks. Thus, the tissues may have suffered autolysis at 
the time of collection or there may have been problems 
associated with the fixation process which could have 
interfered with the antigen/antibody interaction. It is 
also possible that there is some genetic variability that 
has yet to be investigated.
This is the first description of the expression of 
three members of the BPIF protein family (BPIFA1, 
BPIFA2, BPIFB1) in major and minor salivary glands, 
in the palate and in tongue epithelium in human 
fetuses. BPIFA1 expression in the major and minor 
salivary glands begins during the intrauterine period 
but at advanced stages of morphodifferentiation. 
The ciliated cells of the respiratory epithelium also 
produce BPIFA1 in the intrauterine period and, 
for the first time, the expression of BPIFA1 in the 
squamous epithelium of the fetal tongue has been 
recorded. BPIFA2 had extremely limited expression 
in the very early tissues, as the only region to stain 
positively for the presence of this protein was the 
laryngeal pharynx; no expression was found in fetal 
salivary glands. BPIFB1 was detected in only two 
cases studied, and thus requires further investigation. 
Conclusion
BPIFA1 is significantly expressed in early fetal oral 
tissue but BPIFB1 has extremely limited expression 
and the major salivary BPIF protein (BPIFA2) is not 
produced in fetal development. Further studies, with 
more sensitive methods, would allow quantification 
of BPFI protein expression which may lead to a better 
understanding of their role in embryonic development 
and potentially clarification of their post-natal role.
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